Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3

NCT03363854 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

380

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: Tralokinumab
DRUG: Placebo

Sponsor

LEO Pharma